Willms A, Güsgen C, Schreyer C, Becker H-P, Schwab R
Bundeswehrzentralkrankenhaus, Allgemein-/Viszeral- und Thoraxchirurgie, Koblenz, Deutschland.
Zentralbl Chir. 2011 Dec;136(6):592-7. doi: 10.1055/s-0031-1271440. Epub 2011 May 11.
Abdominal vacuum therapy has simplified the treatment of a laparostoma. But is that all that it can achieve? The role of abdominal vacuum therapy concerning the development of small bowel fistulas is still under discussion. Treatment of the bowel surface seems to be crucial for the prevention of fistulas. As military surgeons, we need a simple, standardised regimen, leading to reproducible good results and low complication rates. The question is: are we able to eliminate small bowel fistula during open abdominal treatment?
We analysed 28 consecutive patients with open abdominal treatment in the period of 2004 to 2009. From June 2006 on, we implemented an algorithm, using the KCI V.A.C.® Abdominal Dressing (Kinetic Concepts Inc., San Antonio, Texas, USA) and a vicryl mesh between the non-adherent layer and the foam to prevent fascial retraction. The patients treated -after the installation of the new algorithm were compared to a group treated from 2004 to May 2006 before its installation. Fistula rates, mortality, the fascial closure rate, the number of abdominal dressing changes and the duration of open -abdominal treatment were evaluated.
After implementation of our new algorithm, the fistula rate decreased from 45 % to 0 %. The mortality during open abdominal treatment decreased from 45 % to 6 %. In addition, the duration of open abdominal treatment was reduced as well as the number of dressing changes. The primary fascial closure rate was 87 %.
We implemented a regimen, which is suitable for our mission in Afghanistan, as well as for medical evacuation and for the treatment of patients in our hospitals in Germany. It ensures a standardised treatment of the open abdominal cavity with an ideal protecting treatment of the bowel surface. Our algorithm utilises the advantages of the laparostoma while minimising the complications. The development of a small bowel fistula was eliminated in the evaluated patient group and mortality was clearly reduced.
腹部负压疗法简化了腹壁造口的治疗。但这就是它所能达到的全部效果吗?腹部负压疗法在小肠瘘形成方面的作用仍在讨论中。肠表面的处理似乎对预防瘘至关重要。作为军事外科医生,我们需要一种简单、标准化的方案,以产生可重复的良好效果且并发症发生率低。问题是:在开放性腹部治疗期间,我们能否消除小肠瘘?
我们分析了2004年至2009年期间连续28例接受开放性腹部治疗的患者。从2006年6月起,我们实施了一种方案,使用KCI V.A.C.®腹部敷料(美国得克萨斯州圣安东尼奥市的Kinetic Concepts公司),并在非粘连层和泡沫之间放置一个可吸收缝合线网以防止筋膜回缩。将采用新方案治疗的患者与2004年至2006年5月采用新方案之前治疗的一组患者进行比较。评估瘘发生率、死亡率、筋膜闭合率、腹部敷料更换次数和开放性腹部治疗持续时间。
实施我们的新方案后,瘘发生率从45%降至0%。开放性腹部治疗期间的死亡率从45%降至6%。此外,开放性腹部治疗持续时间以及敷料更换次数均减少。一期筋膜闭合率为87%。
我们实施了一种方案,该方案适用于我们在阿富汗的任务,也适用于医疗后送以及在德国我们医院对患者的治疗。它确保了对开放性腹腔进行标准化治疗,并对肠表面进行理想的保护性处理。我们的方案利用了腹壁造口的优点,同时将并发症降至最低。在所评估的患者组中消除了小肠瘘的发生,且死亡率明显降低。